ARTICLE | Clinical News
Zymafos palifosfamide: Phase III started
July 26, 2010 7:00 AM UTC
Ziopharm began the double-blind, placebo-controlled, international Phase III PICASSO 3 trial to evaluate doxorubicin with or without IV palifosfamide in 424 anthracycline-naïve patients. The company i...